Europabio

EuropaBio Biomanufacturing Policy Summit 2026
2026-07-01 09:30 - 13:30 (Europe/Brussels)
From legislation to impact for Europe

Biomanufacturing lies at the heart of Europe’s future societal and entrepreneurial strength and is changing the business landscape for both emerging innovators and established industry champions.

EuropaBio’s 4th Biomanufacturing Policy Summit will focus on how legislation delivers impact within a proactive Biomanufacturing strategy, and how we establish EU targets for outcomes. It will also showcase the 2026 update of the EuropaBio WIfoR study ‘Measuring the Economic Footprint of the Biotechnology Industry in the European Union’ prior to full report launch in September.

The prize is globally competitive multi-sector biomanufacturing, keeping pace with industrial transition in major global regions and securing Europe’s supply chains, healthcare future, decarbonisation and economic resilience.

This meeting will bring together EuropaBio Members, representatives of key sectors, plus national and EU stakeholders across institutions.

This event will be accessible by invitation only, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org

EFIB Den Haag Statement - A modernised European Union for Industrial Biotechnology
2026-07-13 10:00 - 11:00
EuropaBio’s EFIB Statement presents three clear asks for the European Union:

Ask 1 – Modernising regulation and policy: A dedicated, horizontal EU Regulation for Microorganisms

Ask 2 – Education and awareness: Future-looking stakeholder engagement and Representation

Ask 3 – Financing innovation: Delivering a mature funding and collaborative framework

These asks sit within a progressive legislative mandate for industrial biotechnology and microorganisms. It supports the translation of a competitiveness agenda into legislation that delivers the bioeconomy.

Join EuropaBio for a deep dive into the EFIB Statement and what it means for innovation and manufacturing in the European Union?

AGENDA

Presentation of the EFIB statement: Claire Skentelbery, Director General, EuropaBio

Fireside chat: Giovanni Colombo, Group Senior Director Public Affairs, dsm-firmenich and Board Member EuropaBio

Register Here
